Continued medication important for heart failure patients Date: March 17, 2025 Source: Karolinska Institutet Summary: Patients who have been treated for heart failure and experience an improvement ...

"Based on our study, if you have a patient undergoing TAVI who is at risk of heart failure, it is important to treat them with dapagliflozin or another SGLT-2 inhibitor. These are safe drugs and ...

Patients who have been treated for heart failure and experience an improvement of their pump function, are still at higher risk of heart-related death or hospitalisation if they stop taking heart ...

Patients with heart failure who experience improved heart function remain at increased risk of heart-related death or hospitalization if they discontinue medications such as RASi, ARNi, or MRA.